Search by Drug Name or NDC
NDC 51672-2027-02 Triple Antibiotic Plus Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g Details
Triple Antibiotic Plus Pain Relief 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
Triple Antibiotic Plus Pain Relief is a TOPICAL OINTMENT in the HUMAN OTC DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A., Inc.. The primary component is BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
Related Packages: 51672-2027-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Neomycin, Polymyxin, and Bacitracin Topical
Pramoxine is used to temporarily relieve pain and itching from insect bites; poison ivy, poison oak, or poison sumac; minor cuts, scrapes, or burns; minor skin irritation or rashes; or dry, itchy skin. Pramoxine also may be used to treat soreness, burning, itching, and pain from hemorrhoids (''piles'') and other minor rectal irritations or itching. Pramoxine is in a class of medications called topical anesthetics. It works by stopping nerves from sending pain signals.
Related Packages: 51672-2027-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pramoxine
Product Information
NDC | 51672-2027 |
---|---|
Product ID | 51672-2027_4468ef01-b79c-4d45-8fa5-72650f732236 |
Associated GPIs | 90109804434220 |
GCN Sequence Number | 047690 |
GCN Sequence Number Description | neomycn/bacitrc/polymyx/pramox OINT. (G) 3.5-10K-10 TOPICAL |
HIC3 | Q5W |
HIC3 Description | TOPICAL ANTIBIOTICS |
GCN | 12623 |
HICL Sequence Number | 035595 |
HICL Sequence Number Description | NEOMYCIN SULF/BACITRACIN ZINC/POLYMYXIN B SULF/PRAMOXINE HCL |
Brand/Generic | Generic |
Proprietary Name | Triple Antibiotic Plus Pain Relief |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | OINTMENT |
Route | TOPICAL |
Active Ingredient Strength | 500; 3.5; 10000; 10 |
Active Ingredient Units | [USP'U]/g; mg/g; [USP'U]/g; mg/g |
Substance Name | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Pharmaceutical Class | Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part333B |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 51672-2027-02 (51672202702)
NDC Package Code | 51672-2027-2 |
---|---|
Billing NDC | 51672202702 |
Package | 1 TUBE in 1 CARTON (51672-2027-2) / 28.4 g in 1 TUBE |
Marketing Start Date | 2012-03-31 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.1262 |
Pricing Unit | GM |
Effective Date | 2024-02-21 |
NDC Description | TRIPLE ANTIBIOTIC PLUS OINTMNT |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 4545c043-8e8e-4288-b4d8-e6ec9d72f979 Details
SPL UNCLASSIFIED SECTION
Uses
Warnings
Directions
Adults and children 2 years of age and older:
- clean the affected area and dry thoroughly
- apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
- may be covered with a sterile bandage. Children under 2 years of age: ask a doctor
Other information
PRINCIPAL DISPLAY PANEL - 28.4 g Tube Label
INGREDIENTS AND APPEARANCE
TRIPLE ANTIBIOTIC PLUS PAIN RELIEF
bacitracin zinc, neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride ointment |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - Taro Pharmaceuticals U.S.A., Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Taro Pharmaceuticals Inc. | 206263295 | MANUFACTURE(51672-2027) |